Metraipolis › archive › dc_e6bc6edd5273

Emerging natural product development strategies drive the therapeutic potential exploration and clinical translation of hydroxysafflor yellow A — Europe PMC PMID:42699116

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42699116
DOI
10.1016/j.jpha.2025.101534
License (as archived)
solo-consultazione
Archived
2026-11-07T11:10:14.881Z
SHA-256 of the archived text
095ac60e0badeadd476eaaa3c417bd0a64fb5edc98998220fecf81b5f07fdc1f
Stable URL of this page
https://metraipolis.com/documento/dc_e6bc6edd5273

How to cite

Emerging natural product development strategies drive the therapeutic potential exploration and clinical translation of hydroxysafflor yellow A — Europe PMC PMID:42699116 — Europe PMC (en), https://europepmc.org/article/MED/42699116 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e6bc6edd5273 (Metraipolis archive dc_e6bc6edd5273, sha256 095ac60e0badeadd476eaaa3c417bd0a64fb5edc98998220fecf81b5f07fdc1f)
BibTeX
@misc{dce6bc6edd5273,
  title = {Emerging natural product development strategies drive the therapeutic potential exploration and clinical translation of hydroxysafflor yellow A — Europe PMC PMID:42699116},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42699116},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e6bc6edd5273; sha256 095ac60e0badeadd476eaaa3c417bd0a64fb5edc98998220fecf81b5f07fdc1f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42699116. Agents can read the archived copy with the MCP tool read_document.